Most pharmaceutical companies use one of two approaches to scrub prescription drug script-level data: they either outsource the data cleansing to a third party or they attempt an in-house cleansing. A few go a third route and don’t do anything, resigning themselves to the fact that a certain percentage of revenue will be eroded.

The challenge to script-level validation is the potential for hidden errors, discrepancies or inaccuracies.

Brock Coughlin, Director of Business Value Solutions at Revitas, digs deeper into the issue in his podcast Script-level Data Validation: What Can You Save?

He touches on business issues pharma companies experience around managed care rebate data, the top challenges in script-level validation and offers some solutions that are available.

We’d be interested to learn how your company approaches prescription drug scrubbing?